Jay Sturm - STRATA Skin General Secretary
| SSKN Stock | USD 2.76 0.09 3.37% |
Executive
Jay Sturm is General Secretary of STRATA Skin Sciences
| Age | 69 |
| Address | 5 Walnut Grove Drive, Horsham, PA, United States, 19044 |
| Phone | 215 619 3200 |
| Web | https://www.strataskinsciences.com |
STRATA Skin Management Efficiency
The company has return on total asset (ROA) of (0.0885) % which means that it has lost $0.0885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7349) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of February 2025, Return On Tangible Assets is likely to drop to -0.36. In addition to that, Return On Capital Employed is likely to drop to -0.35. At this time, STRATA Skin's Non Current Assets Total are very stable compared to the past year. As of the 26th of February 2025, Non Currrent Assets Other is likely to grow to about 304.8 K, while Total Assets are likely to drop about 30.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| John Manders | SurModics | 43 | |
| Tom Huang | Sight Sciences | N/A | |
| HsinLiang Lee | Ainos Inc | 54 | |
| Craig Palmer | CVRx Inc | 47 | |
| Lawrence Lin | Ainos Inc | 55 | |
| Harold MBA | Axogen Inc | N/A | |
| MengLin Sung | Ainos Inc | 51 | |
| Florian Tyrs | Artivion | N/A | |
| Carolyn Shelton | Nexalin Technology | 63 | |
| Ivica MD | Axogen Inc | N/A | |
| Amy Treadwell | Neuropace | N/A | |
| Katie Keller | Neuropace | N/A | |
| Jonelle Burnham | CVRx Inc | 54 | |
| Teryl Sides | SurModics | 55 | |
| Sandy Prietto | enVVeno Medical Corp | N/A | |
| CFA CPA | Axogen Inc | 50 | |
| Jens Kemp | Axogen Inc | N/A | |
| Lawrence Lin | Ainos Inc | 55 | |
| Isabelle Billet | Axogen Inc | 62 | |
| Dylan John | Neuropace | N/A | |
| Julie Dewey | Orthofix Medical | 64 | |
Management Performance
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.0885 |
STRATA Skin Sciences Leadership Team
Elected by the shareholders, the STRATA Skin's board of directors comprises two types of representatives: STRATA Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRATA. The board's role is to monitor STRATA Skin's management team and ensure that shareholders' interests are well served. STRATA Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRATA Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dolev Rafaeli, CEO President | ||
| Shmuel Gov, Chief Officer | ||
| John Gillings, Principal Officer | ||
| Robert Moccia, CEO Pres | ||
| William MBA, Ex Chairman | ||
| Michael Stewart, CEO and President and Director | ||
| Michael Goodman, Head Sales | ||
| Darrell Rigel, Chief Advisor | ||
| Keith Simeone, VP Sales | ||
| Nikolai Kabelev, VP RD | ||
| Christopher Lesovitz, Chief Officer | ||
| Jay Sturm, General Secretary |
STRATA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRATA Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.